Drug Discovery Chemistry is a dynamic conference and networking event for drug discovery scientists working in pharma, biotech, and academia. One of the few events that reflects the new cross-functional and collaborative nature of drug discovery, our 2024 speakers and attendees were comprised primarily of pharma and biotech scientists, as well as key academic thought leaders working in translational research. Discussions of chemical tools and approaches to meet the practical (not theoretical) challenges of drug discovery were front and center.
Meaningful one-on-one interactions among our unique audience were maximised via dedicated Q&A segments after each presentation, small group breakout discussions, poster sessions, and networking during refreshment breaks in the exhibit hall. At the same time, the event was large and diverse enough to attract top scientists who shared the latest advances and innovations in early drug discovery.
Pharma/biotech companies presenting include: AstraZeneca, Astex, Bayer Pharma AG, F. Hoffman La Roche, Genentech, Janssen, Johnson & Johnson, Merck KGaA, Novartis, Sanofi, and more. For maximum savings, reserve your place by 27 June.